These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18633158)

  • 21. [Neutralization test for lymphocytic choriomeningitis virus for distinguishing between two arenavirus infections in Argentina].
    Ambrosio AM; Riera L; Saavedra MC; Sottosanti JJ
    Rev Argent Microbiol; 2001; 33(4):235-40. PubMed ID: 11833256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential immune recognition of LCMV nucleoprotein and glycoprotein in transgenic mice expressing LCMV cDNA genes.
    Zeller JC; Nguyen N; Southern PJ
    Virology; 1997 May; 231(2):290-300. PubMed ID: 9168891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection.
    Von Herrath MG; Coon B; Oldstone MB
    Virology; 1997 Mar; 229(2):349-59. PubMed ID: 9126248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different isotype profiles of virus-specific antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice.
    Thomsen AR; Volkert M; Marker O
    Immunology; 1985 Jun; 55(2):213-23. PubMed ID: 4007926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virus-induced immune complex disease: genetic control of C1q binding complexes in the circulation of mice persistently infected with lymphocytic choriomeningitis virus.
    Oldstone MB; Tishon A; Buchmeier MJ
    J Immunol; 1983 Feb; 130(2):912-8. PubMed ID: 6217255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virus-induced immune complex disease: identification of specific viral antigens and antibodies deposited in complexes during chronic lymphocytic choriomeningitis virus infection.
    Buchmeier MJ; Oldstone MB
    J Immunol; 1978 Apr; 120(4):1297-304. PubMed ID: 76662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus.
    Roost H; Charan S; Gobet R; Rüedi E; Hengartner H; Althage A; Zinkernagel RM
    Eur J Immunol; 1988 Apr; 18(4):511-8. PubMed ID: 2452742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interrogating Adaptive Immunity Using LCMV.
    Dangi T; Chung YR; Palacio N; Penaloza-MacMaster P
    Curr Protoc Immunol; 2020 Sep; 130(1):e99. PubMed ID: 32940427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed type-hypersensitivity response of inbred strains of Syrian golden hamsters (Mesocricetus auratus) to lethal or non-lethal lymphocytic choriomeningitis virus (LCMV) infections.
    Genovesi EV; Johnson AJ; Peters CJ
    Microb Pathog; 1989 Nov; 7(5):347-60. PubMed ID: 2622328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.
    Ahmed R; Salmi A; Butler LD; Chiller JM; Oldstone MB
    J Exp Med; 1984 Aug; 160(2):521-40. PubMed ID: 6332167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Origin of lymphocytic-choriomeningitis-virus-bearing mice in Japan.
    Morita C; Suzuki H; Tanikawa T; Yabe T; Eda J; Hirukawa H; Ueno H; Chenchittikal M
    Zentralbl Veterinarmed B; 1994 Jun; 41(4):291-3. PubMed ID: 7839750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of enzyme-linked immunosorbent assay with nucleoprotein as antigen for detection of antibodies to avian influenza virus.
    Jin M; Wang G; Zhang R; Zhao S; Li H; Tan Y; Chen H
    Avian Dis; 2004 Dec; 48(4):870-8. PubMed ID: 15666868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.
    Althage A; Odermatt B; Moskophidis D; Kündig T; Hoffman-Rohrer U; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1992 Jul; 22(7):1803-12. PubMed ID: 1623925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of lymphocytic choriomeningitis virus by use of fluorogenic nuclease reverse transcriptase-polymerase chain reaction analysis.
    Besselsen DG; Wagner AM; Loganbill JK
    Comp Med; 2003 Feb; 53(1):65-9. PubMed ID: 12625508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age distribution of lymphocytic choriomeningitis virus serum antibody in Birmingham, Alabama: evidence of a decreased risk of infection.
    Park JY; Peters CJ; Rollin PE; Ksiazek TG; Katholi CR; Waites KB; Gray B; Maetz HM; Stephensen CB
    Am J Trop Med Hyg; 1997 Jul; 57(1):37-41. PubMed ID: 9242315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analyzing Mouse B Cell Responses Specific to LCMV Infection.
    Hao Y; Li Z; Wang Y; Liu X; Ye L
    Methods Mol Biol; 2018; 1707():15-38. PubMed ID: 29388097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocytic choriomeningitis virus infection in a province of Spain: analysis of sera from the general population and wild rodents.
    Lledó L; Gegúndez MI; Saz JV; Bahamontes N; Beltrán M
    J Med Virol; 2003 Jun; 70(2):273-5. PubMed ID: 12696116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trace-forward investigation of mice in response to lymphocytic choriomeningitis virus outbreak.
    Edison L; Knust B; Petersen B; Gabel J; Manning C; Drenzek C; Ströher U; Rollin PE; Thoroughman D; Nichol ST;
    Emerg Infect Dis; 2014 Feb; 20(2):291-5. PubMed ID: 24447898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of immunologic injury of cultured cells infected with lymphocytic choriomeningitis virus: role of defective interfering virus in regulating viral antigenic expression.
    Welsh RM; Oldstone MB
    J Exp Med; 1977 Jun; 145(6):1449-68. PubMed ID: 301173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of potential novel hosts and the risk of infection with lymphocytic choriomeningitis virus in humans in Gabon, Central Africa.
    Ushijima Y; Abe H; Ozeki T; Ondo GN; Mbadinga MJVM; Bikangui R; Nze-Nkogue C; Akomo-Okoue EF; Ella GWE; Koumba LBM; Nso BCBB; Mintsa-Nguema R; Makouloutou-Nzassi P; Makanga BK; Nguelet FLM; Zadeh VR; Urata S; Mbouna AVN; Massinga-Loembe M; Agnandji ST; Lell B; Yasuda J
    Int J Infect Dis; 2021 Apr; 105():452-459. PubMed ID: 33667697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.